Report cover image

Aircraft Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Product (Gliders, Helicopters, Ultra-Light Aircraft, Passenger Aircraft, Unmanned Aerial Vehicle & Drones, Blimps); By Application; By Region; Segment Forecast, 2022 - 2030

Published Sep 01, 2025
Length 113 Pages
SKU # PLRS20470307

Description

The global aircraft manufacturing market size is expected to reach USD 690.28 billion by 2034 according to a new study by Polaris Market Research. The report “Aircraft Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Product (Gliders, Helicopters, Ultra-Light Aircraft, Passenger Aircraft, Unmanned Aerial Vehicle & Drones, Blimps); By Application; By Region; Segment Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growth of the emerging economies development of the tour & travel industry, coupled with the growing number of passengers for overseas and nationwide travel, are the prime factors for the industry growth across the globe. In addition, increasing investment for technological developments and the growing need to swap outdated airplanes with new & more fuel-efficient and advanced airplanes is also bolstering the airplane manufacturing industry growth. Moreover, rising disposable income in the middle-class population and rising inclination towards reducing airplane weight by the adoption of lightweight parts in order to enhance energy efficiency also creates the productive industry demand in the near future.

Based on the application, the commercial (freight) segment dominates the global airplanes manufacturing industry with the highest revenue shares due to the growing demand for cargo services and the increasing number of import & export activities of goods & services. Also, growing freight traffic and the emergence of the LCC (low-cost carriers) further lead the segment to dominance globally.

Whereas the military & defense segment is showing the highest CAGR rate that leads the airplane manufacturing industry demand. The increasing investment in defense aircraft, along with the rising territorial wars and political welfare, are the prime factors that are fueling the segment demand in the foreseen period.

Growing demand for aircraft for commercial and civil services is the major driving factor for airplane manufacturing industry growth across the globe. The introduction of novel and advanced products for airplane manufacturing is also bolstering the demand. The growing demand for lightweight materials offers several benefits like improved fuel efficiency and lightweight insulation materials in airplanes that offer high strength, flexibility, and corrosion resistance.

Moreover, the increasing air passenger traffic further propels the demand for new airplanes fleets across various countries. Hence, these factors are gaining huge traction among the manufacturers, thus, in turn, accelerating the airplane manufacturing market growth worldwide.

Market participants such as Embraer, Gulfstream Aerospace, Boeing, Bombardier, Cessna Aircraft Company, COMAC, Dassault Falcon, Airbus, United Aircraft Corporation, Hawker Honeywell, Piaggio America Inc., Pilatus Business Aircraft Ltd, Safran Group, and Beechcraft Corp. are some of the key players operating in the global market.

The frequent tactical movements such as mergers & acquisitions, product developments & launches, and others by the prominent market players are supporting the global market development. For instance, in May 2021, Dassault Aviation declares the launch of its new Falcon jet featuring the industry’s largest cabin and most advanced technology on a business jet. The product offers a high level of comfort, versatility, and technology unmatched by any purpose-built business jet.

Polaris Market Research has segmented the aircraft manufacturing market report on the basis of product, application, and region:

Aircraft Manufacturing, Product Outlook (Revenue - USD Billion, 2020 - 2034)

Gliders

Helicopters

Ultra-Light

Passenger

Unmanned aerial vehicles & drones

Blimps (Airship)

Aircraft Manufacturing, Application Outlook (Revenue - USD Billion, 2020 - 2034)

Military &defense

Civil

Commercial (Freight)

Others

Aircraft Manufacturing, Regional Outlook (Revenue - USD Billion, 2020 - 2034)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Spain

Netherlands

Austria

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

113 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market Insights
4.1. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market – Market Snapshot
4.2. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Aging Population and Demographic Shift
4.2.1.2. Rising Healthcare Spending
4.2.2. Restraints and Challenges
4.2.2.1. Regulatory and market access barriers
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market Trends
4.6. Value Chain Analysis
5. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Type
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Type, 2020-2034 (USD Million)
5.3. Therapy
5.3.1. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Therapy, by Region, 2020-2034 (USD Million)
5.3.2. Chemotherapy
5.3.2.1. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Chemotherapy, by Region, 2020-2034 (USD Million)
5.3.3. Immunotherapy
5.3.3.1. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Immunotherapy, by Region, 2020-2034 (USD Million)
5.3.4. Stem Cell Transplantation
5.3.4.1. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Stem Cell Transplantation, by Region, 2020-2034 (USD Million)
5.4. Diagnostic
5.4.1. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Diagnostic, by Region, 2020-2034 (USD Million)
5.4.2. Flow Cytometry
5.4.2.1. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Flow Cytometry, by Region, 2020-2034 (USD Million)
5.4.3. Molecular Testing
5.4.3.1. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Molecular Testing, by Region, 2020-2034 (USD Million)
5.4.4. Histopathology
5.4.4.1. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Histopathology, by Region, 2020-2034 (USD Million)
5.4.5. Imaging Techniques
5.4.5.1. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Imaging Techniques, by Region, 2020-2034 (USD Million)
6. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by End User
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by End User, 2020-2034 (USD Million)
6.3. Hospitals
6.3.1. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Hospitals, by Region, 2020-2034 (USD Million)
6.4. Specialty Clinics
6.4.1. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Specialty Clinics, by Region, 2020-2034 (USD Million)
6.5. Diagnostic Laboratories
6.5.1. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
6.6. Others
6.6.1. U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Others, by Region, 2020-2034 (USD Million)
7. Competitive Landscape
7.1. Expansion and Acquisition Analysis
7.1.1. Expansion
7.1.2. Acquisitions
7.2. Partnerships/Collaborations/Agreements/Exhibitions
8. Company Profiles
8.1. AbbVie Inc.
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Recent Development
8.2. Jazz Pharmaceuticals, Inc.
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Recent Development
8.3. Menarini Group
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Recent Development
8.4. F Hoffmann Roche
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Recent Development
8.5. Mustang Bio
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Recent Development
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.